RESPIFERON
As part of the REVIDA Chair, an article highlighting the use of the Type-I Interferon response as a universal marker for respiratory viral infections was recently accepted by the eBioMedicine journal. Titled “Advancing Respiratory Virus Diagnostics: Integrating the...
Literature review
Kylian TREPAT, doctoral student at the UCBL/HCL/bioMérieux joint research laboratory, published “Exploring viral respiratory coinfections: Shedding light on pathogen interactions” in September 2024, in PLoS Pathogens. This review of the literature, in the “Pearls”...
Launch of the Chair
On October 11, 2023, the REVIDA Industrial Chair (Respiratory Viral Infections: From Diagnosis to Prognosis), led by researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the University Claude Bernard Lyon 1, the Hospices Civils de Lyon, and...